Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus casei fermented cow's milk is a nutritional intervention being investigated for its neuroprotective effects, particularly in attenuating neuroinflammation and memory impairment. Studies have shown its ability to reduce lipopolysaccharide-induced memory deficits in mice. Its mechanism of action involves anti-inflammatory and antioxidative activities, including the inhibition of acetylcholinesterase (AChE), reduction of pro-inflammatory cytokines, and enhancement of antioxidant enzymes like superoxide dismutase (SOD), glutathione (GSH), and glutathione peroxidase (GPx), while decreasing malondialdehyde (MDA) and nitric oxide (NO) levels. It is considered a functional food or nutraceutical with potential applications in conditions like Alzheimer's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactobacillus casei fermented cow's milk.